Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canntab Therapeutics Ltd CTABF

Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and consumers with medical grade solutions. These include once a day and extended-release formulations. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet (ODT). The IR Tablet is a release profile for solid hard tablets. The XR Tablet is a phytocannabinoid vehicle that is designed to directly address the drawbacks and challenges of competing oral delivery systems. ODT is specifically designed to dissolve directly in the patient’s mouth, with an onset of action between five and thirty minutes.


GREY:CTABF - Post by User

Canntab Therapeutics Ltd > Sorry for those who got tricked by TFS, but...
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by Eppyon May 01, 2018 2:10pm
147 Views
Post# 27965671

RE:Sorry for those who got tricked by TFS, but...

RE:Sorry for those who got tricked by TFS, but...I agree with your observation.  Volume is down now so I think the weak hands are almost gone.  What is needed now is patience.  PILL still needs to get final approval from Health Canada which is a process they will have no control over.  We should see a slow steady rise here for the next few months but I don't think the reail sp gains won't be until 2019.  HC approval and marketing of their line of medicianl pills  along with 3rd party research into the real benefits of medicinal marjiuana will result in the share price to take off.  For example, research is now be undertaken to see how medicinal marijuana can help those suffering with chones and colitis.  In addition, more and more experts are starting to come out and express the opinion that medicinal marijuana could be one of the tools to get a handle on the opiod crisis in North America.  CNN just did a special report on this last Sunday.  All this will benefit PILL once it gets Health Canada Approval  We just need to be patient.   GLTA
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities